Profund Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,214
Closed -$200K 1244
2026
Q1
$200K Sell
2,214
-1,010
-31% -$92.7K 0.01% 1032
2025
Q4
$290K Buy
3,224
+668
+26% +$63.3K 0.01% 902
2025
Q3
$252K Buy
2,556
+29
+1% +$2.87K 0.01% 846
2025
Q2
$230K Sell
2,527
-194
-7% -$18.8K 0.01% 822
2025
Q1
$308K Sell
2,721
-80
-3% -$8.56K 0.01% 659
2024
Q4
$296K Sell
2,801
-573
-17% -$61.5K 0.01% 770
2024
Q3
$364K Buy
3,374
+247
+8% +$27K 0.01% 695
2024
Q2
$339K Sell
3,127
-68
-2% -$8.02K 0.01% 651
2024
Q1
$422K Sell
3,195
-379
-11% -$47.3K 0.02% 658
2023
Q4
$435K Buy
3,574
+365
+11% +$40.7K 0.02% 584
2023
Q3
$360K Sell
3,209
-8
-0.2% -$1.02K 0.02% 575
2023
Q2
$468K Buy
3,217
+60
+2% +$8.15K 0.03% 537
2023
Q1
$408K Sell
3,157
-455
-13% -$57.1K 0.03% 575
2022
Q4
$461K Buy
3,612
+384
+12% +$44.6K 0.03% 440
2022
Q3
$337K Sell
3,228
-237
-7% -$26K 0.02% 532
2022
Q2
$364K Sell
3,465
-403
-10% -$47.8K 0.02% 533
2022
Q1
$495K Sell
3,868
-506
-12% -$61K 0.02% 577
2021
Q4
$540K Buy
4,374
+135
+3% +$17.7K 0.02% 563
2021
Q3
$602K Buy
4,239
+35
+0.8% +$5.15K 0.02% 540
2021
Q2
$656K Buy
4,204
+41
+1% +$6.64K 0.02% 522
2021
Q1
$647K Sell
4,163
-216
-5% -$33.5K 0.02% 458
2020
Q4
$655K Sell
4,379
-72
-2% -$10.2K 0.03% 432
2020
Q3
$588K Sell
4,451
-1,081
-20% -$141K 0.03% 409
2020
Q2
$641K Buy
5,532
+1,396
+34% +$161K 0.04% 355
2020
Q1
$406K Sell
4,136
-1,912
-32% -$251K 0.03% 404
2019
Q4
$879K Buy
6,048
+554
+10% +$76.5K 0.04% 389
2019
Q3
$732K Sell
5,494
-732
-12% -$94.6K 0.04% 436
2019
Q2
$712K Sell
6,226
-1,607
-21% -$188K 0.03% 487
2019
Q1
$971K Buy
7,833
+588
+8% +$66.8K 0.05% 351
2018
Q4
$730K Sell
7,245
-1,391
-16% -$156K 0.05% 354
2018
Q3
$1.1M Buy
8,636
+2,206
+34% +$262K 0.04% 368
2018
Q2
$696K Sell
6,430
-583
-8% -$63.5K 0.03% 554
2018
Q1
$742K Sell
7,013
-195
-3% -$22.6K 0.03% 568
2017
Q4
$844K Sell
7,208
-2,403
-25% -$272K 0.03% 541
2017
Q3
$1.09M Buy
9,611
+751
+8% +$86.7K 0.05% 381
2017
Q2
$1.1M Buy
8,860
+524
+6% +$62.1K 0.05% 348
2017
Q1
$988K Buy
8,336
+893
+12% +$101K 0.04% 447
2016
Q4
$746K Sell
7,443
-579
-7% -$62.1K 0.03% 621
2016
Q3
$1.01M Sell
8,022
-335
-4% -$41.4K 0.05% 383
2016
Q2
$977K Sell
8,357
-372
-4% -$42.1K 0.05% 408
2016
Q1
$904K Sell
8,729
-1,038
-11% -$100K 0.05% 395
2015
Q4
$973K Sell
9,767
-1,323
-12% -$129K 0.05% 365
2015
Q3
$1.01M Sell
11,090
-3,415
-24% -$342K 0.06% 284
2015
Q2
$1.54M Buy
14,505
+984
+7% +$109K 0.06% 253
2015
Q1
$1.54M Buy
13,521
+318
+2% +$36.3K 0.06% 289
2014
Q4
$1.45M Buy
13,203
+2,335
+21% +$246K 0.06% 291
2014
Q3
$1.06M Buy
10,868
+1,876
+21% +$185K 0.05% 362
2014
Q2
$907K Sell
8,992
-1,472
-14% -$144K 0.04% 538
2014
Q1
$961K Buy
10,464
+1,430
+16% +$132K 0.04% 487
2013
Q4
$817K Buy
9,034
+248
+3% +$21.5K 0.04% 656
2013
Q3
$701K Buy
8,786
+809
+10% +$63.7K 0.04% 685
2013
Q2
$580K Buy
+7,977
New +$596K 0.04% 544

Other funds holding ZBH

Profund Advisors's ZBH Position: Q2 2026 in Review

Profund Advisors sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 2,214 shares — an estimated $200K sold.

Profund Advisors first reported a position in ZBH in Q2 2013 and held it in 52 quarters. The position peaked at $1.54M in Q1 2015. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Profund Advisors reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
  • Profund Advisors sold 2,214 Zimmer Biomet shares in Q2 2026, an estimated $200K.
  • Profund Advisors first reported a position in Zimmer Biomet in Q2 2013 and held it in 52 quarters.
  • Profund Advisors's Zimmer Biomet position peaked at $1.54M in Q1 2015.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.